Before the Thanksgiving holiday, the Centers for Medicare & Medicaid Services (CMS) unveiled two proposed regulations that could bring about significant changes to certain health insurance plan policies starting from 2025. These regulations would impact two distinct markets – the Medicare Advantage (MA) health plans and those that offer prescription drug coverage under Medicare Part D, as well as the health plans that operate in the federal and state “Marketplaces” instituted by the Affordable Care Act. The proposal, however, implies the similar overarching goal of making affordable healthcare more accessible to all.
The proposed regulations aim to provide a more competitive and fair marketplace for MA health plans and prescription drug coverage under Medicare Part D. The amendments include updating and enhancing the Star Ratings for Medicare Advantage and Part D plans to incorporate a measure of health equity.
Concurrently, CMS proposes changes to health plans operating in the federal and state “Marketplaces” to promote accessibility of affordable care. Such changes involve providing more flexibility to state innovation waivers, which allows states to depart from certain Affordable Care Act requirements provided they achieve the same coverage results without additional federal costs.
Despite the distinctly different markets, the regulations have a shared policy goal – to optimize the availability and accessibility of affordable healthcare coverage. By fostering competitiveness and ensuring fair practices in the marketplace, the CMS aims at a healthcare system that centers on the welfare of the beneficiaries. As the proposed changes are analyzed in further detail by legal professionals and stakeholders, it becomes imperative to monitor how this regulatory landscape would evolve and the potential impact it could have on both the providers and the recipients of healthcare coverage.